Výsledky vyhledávání

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

Autor: Shin Mineishi, Christopher Ehmann, David F. Claxton, Valerie I. Brown, Neal Shah, Witold B. Rybka, Joseph Mierski, Gina Mackey, Hong Zheng, Myles Nickolich, Seema Naik, Kentaro Minagawa, Baldeep Wirk, Robert J. Greiner, Kevin Rakszawski, Brooke Silar

Publikováno v: Annals of hematology. 100(10)

Acute myeloid leukemia (AML) relapse after allogeneic stem cell transplant (alloSCT) remains a major therapeutic challenge. While patients with longer remission after initial alloSCT are recommended to receive cell therapy (CT) such as 2ndalloSCT or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20932843a86fff0ba55c7b8bb036141
https://pubmed.ncbi.nlm.nih.gov/34322774

Zobrazit plný text záznamu

Engraftment Kinetics and Recipient Chimerism Increase to Predict Leukemia Relapse By Ptcy and Non-Ptcy Transplant

Autor: Shin Mineishi, Brooke Silar, Seema Naik, Joseph Mierski, Witold B. Rybka, W. Christopher Ehmann, Ruoheng Zhang, Hiroko Shike, Hong Zheng, Baldeep Wirk, Shouhao Zhou, David F. Claxton, Jason Liao, Valerie I. Brown, Kevin Rakszawski, Kentaro Minagawa, Gina Mackey, Robert J. Greiner, Myles Nickolich

Publikováno v: Blood. 138:1792-1792

Recipient chimerism increase has been used to predict leukemia relapse in post-hematopoietic cell transplant (HCT) patients with conventional GVHD prophylaxis. However, the value of recipient chimerism increase in patients with post-transplant cyclop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e84f08fe4e5cc71fa16361be8808b8fd
https://doi.org/10.1182/blood-2021-148872

Zobrazit plný text záznamu

Post-Transplant Cyclophosphamide As GVHD Prophylaxis Eliminates GVHD Mortality and Improves Overall Survival in Alternative Donor Allogeneic Stem Cell Transplant

Publikováno v: Transplantation and Cellular Therapy. 27:S241-S242

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1b05ec9470485882219d8b5dfc6cb2b
https://doi.org/10.1016/s2666-6367(21)00301-8

Zobrazit plný text záznamu

Improved Outcome for AML Relapse after Allogeneic Transplant with High Intensity Chemotherapy Followed By 2nd Allogeneic Stem Cell Transplant or Donor Lymphocyte Infusion; A Retrospective Analysis

Autor: Baldeep Wirk, Brooke Silar, Shin Mineishi, David F. Claxton, Kentaro Minagawa, Hong Zheng, Witold B. Rybka, Robert J. Greiner, Neal Shah, Joseph Mierski, Kevin Rakszawski, Seema Naik, Valerie I. Brown, W. Christopher Ehmann, Myles Nickolich, Gina Mackey

Publikováno v: Biology of Blood and Marrow Transplantation. 26:S99-S100

Background Acute myeloid leukemia (AML) relapse after allogeneic stem cell transplant (allo SCT) remains a major therapeutic challenge. While patients with longer remission after initial allo SCT are recommended to receive either 2nd allo SCT or dono

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bef458b132ccc18b18f6ca0578c5285e
https://doi.org/10.1016/j.bbmt.2019.12.601

Zobrazit plný text záznamu

Patterns of Transplants and Survival Outcomes for Mantle Cell Lymphoma over Last 17 Years: Single Center Experience

Autor: Gina Mackey, Seema Naik, Witold Rybka, Shin Mineishi, W. Christopher Ehmann, Hong Zheng, David F. Claxton, Kentaro Minagawa, Kevin Rakszawski

Publikováno v: Biology of Blood and Marrow Transplantation. 26:S246-S247

Introduction Mantle cell lymphoma (MCL) is aggressive disease with poor survival by chemotherapy alone. Both autologous (auto SCT) and allogeneic stem cell transplants (allo SCT) have improved outcome over years but strategies have not been clearly d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::837e8c354489a41896da98b0b624ebb2
https://doi.org/10.1016/j.bbmt.2019.12.496

Zobrazit plný text záznamu

Non-Myeloablative Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia: Graft-Versus-Host Disease Potentiates Graft-Versus-Leukemia Effect and Improves Overall Survival

Autor: Shin Mineishi, Gina Mackey, W. Christopher Ehmann, Christopher J Pizzola, Witold B. Rybka, Brook Silar, Kevin Rakszawski, Kentaro Minagawa, Hong Zheng, Baldeep Wirk, Seema Naik, David F. Claxton

Publikováno v: Blood. 134:5724-5724

Introduction: Non-myeloablative conditioning regimens enable elderly and younger patients with significant comorbidities to undergo allogenic stem cell transplant (allo SCT). These regimens allow for the benefit of graft-versus-leukemia (GVL) effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f8c5ab2eec2a17642ea53abd6682139
https://doi.org/10.1182/blood-2019-128817

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání